Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation

被引:315
作者
Wada, R
Tifft, CJ
Proia, RL
机构
[1] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
[2] Childrens Natl Med Ctr, Dept Med Genet, Washington, DC 20010 USA
关键词
microglia; macrophage; apoptosis; cDNA microarray; tumor necrosis factor-alpha;
D O I
10.1073/pnas.97.20.10954
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Sandhoff disease is a lysosomal storage disorder characterized by the absence of beta-hexosaminidase and storage of G(M2) ganglioside and related glycolipids in the central nervous system. The glycolipid storage causes severe neurodegeneration through a poorly understood pathogenic mechanism. In symptomatic Sandhoff disease mice, apoptotic neuronal cell death was prominent in the caudal regions of the brain. cDNA microarray analysis to monitor gene expression during neuronal cell death revealed an upregulation of genes related to an inflammatory process dominated by activated microglia. Activated microglial expansion, based on gene expression and histologic analysis, was found to precede massive neuronal death. Extensive microglia activation also was detected in a human case of Sandhoff disease. Bone marrow transplantation of Sandhoff disease mice suppressed both the explosive expansion of activated microglia and the neuronal cell death without detectable decreases in neuronal G(M2) ganglioside storage. These results suggest a mechanism of neurodegeneration that includes a vigorous inflammatory response as an important component. Thus, this lysosomal storage disease has parallels to other neurodegenerative disorders, such as Alzheimer's and prion diseases, where inflammatory processes are believed to participate directly in neuronal cell death.
引用
收藏
页码:10954 / 10959
页数:6
相关论文
共 39 条
  • [1] Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123
  • [2] BRAIN MICROGLIA CONSTITUTIVELY EXPRESS BETA-2 INTEGRINS
    AKIYAMA, H
    MCGEER, PL
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1990, 30 (01) : 81 - 93
  • [3] Aoki T, 1999, CLIN NEUROPATHOL, V18, P51
  • [4] BIANCA VD, 1999, J BIOL CHEM, V274, P15493
  • [5] Combs CK, 1999, J NEUROSCI, V19, P928
  • [6] MICROGLIA - INTRINSIC IMMUNEFFECTOR CELL OF THE BRAIN
    GEHRMANN, J
    MATSUMOTO, Y
    KREUTZBERG, GW
    [J]. BRAIN RESEARCH REVIEWS, 1995, 20 (03) : 269 - 287
  • [7] Giese A, 1998, BRAIN PATHOL, V8, P449
  • [8] Gravel RA., 1995, The metabolic and molecular bases of inherited disease, V7th, P2839
  • [9] Neuronal apoptosis in Creutzfeldt-Jakob disease
    Gray, F
    Chrétien, F
    Adle-Biassette, H
    Dorandeu, A
    Ereau, T
    Delisle, MB
    Kopp, N
    Ironside, JW
    Vital, C
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (04) : 321 - 328
  • [10] MARKED ELEVATION OF PLASMA CHITOTRIOSIDASE ACTIVITY - A NOVEL HALLMARK OF GAUCHER DISEASE
    HOLLAK, CEM
    VANWEELY, S
    VANOERS, MHJ
    AERTS, JMFG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) : 1288 - 1292